Skip to content

Unani treatment for Cervical erosion

Effect of Marhame BÄ?salÄ«qÅ«n in Qurūḥ al Raḥim (Cervical Erosion): A Randomized comparative clinical study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040419
Enrollment
40
Registered
2022-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

Intervention1: Tablet azithromycin and tablet cefexime Marhame bÄ?salÄ«qÅ«n: Standard antibiotic regime include single dose of (Tablet cefixime 400 mg & Tablet azithromycin 1 g one hour before lunch)

Sponsors

National Institute Of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Married women in the age group of 20 to 45 years 2 Cervical erosion on speculum examination 3 Normal or inflammatory pap smear

Exclusion criteria

Exclusion criteria: 1 Patient with PID & STDâ??s. 2 Systemic diseases & Malignancies. 3 H/O using OCPs & IUCDâ??s.(in last 3 months) 4 Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Cervical erosion grading scale scoreTimepoint: Follow up of patients will be done weekly once during the trial and once after two weeks of completion of trial

Secondary

MeasureTime frame
1 Vaginal discharge 2 Lower abdominal pain 3 Low back ache 4 Pruritus vulvae 5 Post coital bleeding Timepoint: Follow up of patients will be done weekly once during the trial and once after two weeks of completion of trial

Countries

India

Contacts

Public ContactProfessor Ismath Shameem

National Institute Of Unani Medicine

dr.ismaths@gmail.com9449977008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 5, 2026